Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma

Ovarian carcinoma has the highest mortality among the malignant tumours in gynaecology, and new treatment strategies are urgently needed to improve the clinical status of ovarian carcinoma patients. The Cancer Genome Atlas (TCGA) cohort were performed to explore the immune function of the internal e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Mol Med
Autors principals: Zheng, Mingjun, Hu, Yuexin, Gou, Rui, Liu, Ouxuan, Nie, Xin, Li, Xiao, Liu, Qing, Hao, Yingying, Liu, Juanjuan, Lin, Bei
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7077593/
https://ncbi.nlm.nih.gov/pubmed/31995855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14830
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars